Approval · Notice of Compliance 37136 · 2026
ODAN-ARIPIPRAZOLE SOLUTION: Notice of Compliance 37136
Issued March 18, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37136
- Date
- March 18, 2026
- Company
- Odan Laboratories Ltd.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ODAN-ARIPIPRAZOLE SOLUTION | 02566788 | Marketed |
Medicinal ingredients
- ARIPIPRAZOLE 1 MG per ML